MOH — authorised 10 October 2019
- Marketing authorisation holder: VERTEX PHARMS INC
- Status: likely_approved
MOH authorised Trikafta (Copackaged) on 10 October 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 10 October 2019.
VERTEX PHARMS INC holds the UAE marketing authorisation.